ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
32 hedge funds and large institutions have $213M invested in ESSA Pharma in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
15% more capital invested
Capital invested by funds: $185M → $213M (+$27.6M)
3% more funds holding
Funds holding: 31 → 32 (+1)
0.26% less ownership
Funds ownership: 79.37% → 79.11% (-0.26%)
46% less call options, than puts
Call options by funds: $120K | Put options by funds: $224K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$5.29M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$515K |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$426K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$153K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$36.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$5.19M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.22M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$207K |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$54.9K |
| 5 |
Two Sigma Investments
New York
|
-$54.2K |
EPIX Hedge Fund Activity: Q3 2024 in Review
32 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q3 2024, worth a combined $213M — up 15% from $185M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new EPIX positions and 3 closed out — a net gain of 1 holder — while 10 added to existing stakes and 7 trimmed.
The largest buyer was RTW Investments, adding an estimated $5.29M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $5.19M sold.
- 32 institutional investors held ESSA Pharma (EPIX) as of Q3 2024, up from 31 in Q2 2024.
- Funds reported $213M of ESSA Pharma stock for Q3 2024, up 15% quarter-over-quarter.
- 4 funds opened new ESSA Pharma positions in Q3 2024 and 3 closed out, a net change of +1 holder.
- The largest ESSA Pharma buyer in Q3 2024 was RTW Investments, an estimated $5.29M added.
- The largest ESSA Pharma seller in Q3 2024 was Janus Henderson Group, an estimated $5.19M sold.
Based on aggregated 13F filings for Q3 2024.